Navigation Links
Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
Date:5/5/2008

ed their child's pain

as significantly lower than parents of children receiving the sham

placebo device (p<0.001).(1)

Zingo was found to be well tolerated in this patient population, with no serious drug-related adverse events reported. The most common skin assessment findings were redness (erythema), red dots (petechiae) and swelling (edema) at the site of administration. The incidence of adverse events with Zingo was no higher than with sham placebo.(1) Demographic characteristics and sites of administration were evenly distributed across treatment groups.

The U.S. Food and Drug Administration (FDA) approved Zingo last year for children three to 18 years of age based on the results of the COMFORT-003 study and a second large clinical trial, COMFORT-004, which also found that use of Zingo was related to significantly less peripheral venous access procedural pain in children.

About Zingo and Venous Access Procedures

Zingo is a needle-free system that delivers lidocaine powder into the skin and provides analgesia in one to three minutes after administration.

In clinical trials, Zingo was well-tolerated. The most common adverse reactions in clinical trials were erythema, petechiae, and edema at the site of administration.(7) Full prescribing information is available at http://www.anesiva.com/img/ZingoPackage.pdf.

In addition to the hospital population, opportunities exist for Zingo in children in hemodialysis centers, as well as physicians' offices and clinical laboratories. In March, Anesiva submitted a supplemental New Drug Application with the U.S. Food and Drug Administration to expand the indication for Zingo to treat the pain associated with peripheral IV insertions and blood draws in adults.

About Anesiva and its Diverse Pipeline of Pain Products

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
2. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
3. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
4. Anesiva Defines Regulatory Pathway for Adlea with FDA
5. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
6. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
7. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
8. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
10. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
11. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... , June 18, 2013  It has ... of Alliance Seating and Mobility, a subsidiary company ... access timely repair. This appears to be due ... reduction of field service employees.  ... great many of these clients are complex mobility ...
(Date:6/18/2013)... 2013  Recent regulatory and budget challenges have made ... at large pharmaceutical companies to effectively educate doctors and ... of their new products. With the pressure to reduce ... that these "Med Ed" groups find practical, ... address the changes that are transforming the Medical Education ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... Sept. 16 The American,Chemistry Council is aware ... today in,the Journal of the American Medical Association ... concentrations and medical,disorders in adults. As with any ... design of a study can limit interpretation of ...
... Biotech Begins to Demonstrate Strategy to Expand NHL ... Preclinical Development Program -, BRITISH COLUMBIA, Canada, ... OTC Bulletin Board: IXSBF;, http://www.ixsbio.com ), a drug ... based on its technology, Dynamic Cross,Linking (DXL(TM)), announced ...
Cached Medicine Technology:New Bisphenol A Study Has Limited Capability to Assess Human Health Effects 2InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies 2InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies 3
(Date:6/19/2013)... California (PRWEB) June 19, 2013 GoTunes ... iPhone, a free music and fitness app for creating ... can discover new Spotify songs that match your exercise ... they exercise, and add songs to your favorite playlists. ... songs curated by the GoTunes staff. , Get the ...
(Date:6/19/2013)... Weight gain and obesity have been ... including heart disease, kidney failure and high blood pressure. ... and unnecessary fat, have many people searching for fast ... diets to not only allow patients to succeed ... aim to reduce the risk for many weight-related health ...
(Date:6/19/2013)... After investing efforts for months in this ... announced the launch of database integration for the 2012 ... entry in the list of extraordinary vehicles lined up ... 2012 Nissan NV is all ready to get good ... Provided with two high power capable engines, the 2012 ...
(Date:6/19/2013)... Gainesville, FL (PRWEB) June 19, 2013 ... a new treatment solution for tinnitus patients, the ... medical term for noise or ringing in the ... of something serious within the body. , Using ... device creates a customizable and comforting sound stimulus ...
(Date:6/19/2013)... Miami, Florida (PRWEB) June 19, 2013 ... York Magazine, drug abusers called “psychonauts” are creating new ... based on their research of published documents and patented ... Here & Now on June 4. ... even physiologic effects. They’re never tested on humans. Maybe ...
Breaking Medicine News(10 mins):Health News:The GoTunes Iphone App Creates a Streaming Workout Music Community Via Spotify 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3
... ... imaging system for use in surveillance, defense, medical and machine vision applications. The embedded ... the potential to create a smart grid of imaging systems. , ... Rochester, NY (PRWEB) June 10, 2009 ...
... with rapid eye movement (REM) sleep refresh the brain,s ... negative bias and amplifying recognition of positive emotions, according ... Wednesday, June 10, at SLEEP 2009, the 23rd Annual ... show that the emotional brain is not stable across ...
... be Unveiled by SharpBrains CEO on June 11th, during Games for ... June 9 How can you take care of your brain ... which seem to contradict each other? Do supplements improve memory? Do ... of them enough? Which brain training approach, if any, is worth ...
... 2009In a joint effort by national laboratory-, university- and ... characterizing biological pathogens that could give rise to potentially ... first tool, an automated genotyping system, is a joint ... California at Los Angeles (UCLA) School of Public Health, ...
... could be key to a restful night, study finds , ... turning and having trouble getting a good night,s sleep, you ... primary insomnia reported that they slept better after trying meditation, ... at SLEEP, the annual meeting of the Associated Professional Sleep ...
... 9 Allied World Assurance,Company (U.S.) Inc., a member ... AWH ), today announced an added service to ... States. The,complimentary service, called "Strategic Response(SM)," provides policyholders,with 24/7 ... of a catastrophe. , Gordon ...
Cached Medicine News:Health News:FluxData, Inc. Introduces New Multispectral Camera with Embedded PC104 Computer 2Health News:FluxData, Inc. Introduces New Multispectral Camera with Embedded PC104 Computer 3Health News:Naps with rapid eye movement sleep increase receptiveness to positive emotion 2Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 2Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 3Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 4Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 5Health News:Fast pandemic detection tool ready to fight flu 2Health News:Fast pandemic detection tool ready to fight flu 3Health News:Meditation May Help Put Primary Insomnia to Bed 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 3
Streck-Diluent CD is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1800....
... balanced electrolyte solution manufactured for use as ... sizing. Streck-Diluent III is for use on ... JS, JT, S-Plus IV, V, VI with ... 1400 and 1600. The shelf life is ...
Streck-Detergent III is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured for the Abbott CELL-DYN® 1400, 1600, 3500 and 3700. The shelf life...
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
Medicine Products: